ClearRead Xray - Compare

Riverain Technologies

ClearRead Compare is an image registration and enhancement application that accentuates interval change between current and prior chest X-ray exams by forming a subtraction image.

Information source: Vendor
Last updated: June 20, 2022

General Information

General
Product name	ClearRead Xray - Compare
Company	Riverain Technologies
Subspeciality	Chest
Modality	X-ray
Disease targeted	Lung cancer
Key-features	Multiple time-point analysis
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)

Technical Specifications

Data characteristics
Population	Adult, not pediatric
Input	Current and prior PA/AP chest view, showing both lungs
Input format	DICOM
Output	Differences between current and prior images as grayscale values ranging from dark to light.
Output format	DICOM Secondary Capture
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis	Automatically, right after the image acquisition
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDR
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)	Compare is intended to generate a secondary residual image based on a current and prior chest x-ray image of the same patient, resulting in improved visibility of lung nodules. The Compare image provides adjunctive information and is not a substitute for the original PA/AP image. This device is intended to be used by trained professionals, such as physicians, radiologists, and technicians on patients with risk of having lung nodules and is not intended to be used on pediatric patients.

Market

Market presence
On market since	12-2011
Distribution channels	Sectra Amplifier Store, Aidoc aiOS, Volpara Health, GE Healthcare
Countries present (clinical, non-research use)	13
Paying clinical customers (institutes)	200+
Research/test users (institutes)	6
Pricing
Pricing model	Subscription, One-time license fee
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers